Published online and peer-reviewed in October 2021, this meta-study examined retrospective self-reported archival data from the Strainprint App. They focused specifically on those patients with endometriosis-associated pelvic pain.
The study included 252 participants suffering from endometriosis who recorded over 16,000 individual sessions of cannabis use. Inhaled forms were reported to be most effective for pain, while oral forms were best for mood and gastrointestinal issues.
"Cannabis appears to be effective for pelvic pain, gastrointestinal issues and mood, with effectiveness differing based on method of ingestion."
The full-text article is here from Plos.org.